Sanofi Pasteur Korea said it received marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its invasive meningococcal vaccine, MenQuadfi (meningococcal (A, C, Y, W) polysaccharide-TT protein conjugate vaccine) on Wednesday last week.MenQuadfi is a fully liquid vial quadrivale
Olympus, a Japan-based global medical device company, has decided to terminate its acquisition of Taewoong Medical, a Korea-based specialist in gastrointestinal stents, just two months after announcing the deal in January.The decision comes after Olympus discovered issues related to data integrity i
Daehwa Pharm, a Kosdaq-listed drugmaker, said Friday it received orphan drug designation (ODD) from the European Medicines Agency (EMA) for Liporaxel Solution, an oral paclitaxel, for the second-line treatment of gastric cancer on Feb. 26.Daehwa explained that the orphan drug designation for Liporax
GC Medical Science (GC MS) said Friday that it has signed an agreement for the long-term supply of hemodialysis solutions with Baxter Korea’s Kidney Business Division.GC MS has supplied hemodialysis solutions to Baxter for the past five years, from 2019 to 2023. With the latest agreement, GC MS will
Genexine and Handok said Friday that GX-H9 (HL2356), a long-acting growth hormone for pediatric use under co-development by the two, has been designated as an orphan drug in the developmental stage by the Ministry of Food and Drug Safety (MFDS).According to the companies, the designation of GX-H9 as
Medytox posted a significant year-over-year drop in profits last year. The company attributed it to ongoing litigation and other reasons while predicting its performance will improve this year.On Thursday, Medytox released its preliminary consolidated operating results for 2023 through a public disc
Coreline Soft has won two main awards at the International Forum Design Award 2024 (iF Design Award 2024), an international design competition in Germany.The iF Design Award is the longest-running international design award and is considered one of the world's top three design awards, along with the
The prevalence of heart failure in Korea is steadily rising due to population aging.According to Factsheet 2022, published by the Korean Society of Heart Failure, the prevalence rate in Korea increased significantly from 0.77 percent in 2002 to 2.58 percent in 2020. The number of hospitalizations fo
The second-generation bruton tyrosine kinase (BTK) inhibitor Brukinsa (zanubrutinib), developed by BeiGene, has cleared the threshold of the Pharmaceutical Reimbursement Evaluation Committee (PREC) after a second attempt at expanded coverage.At the same meeting, AstraZeneca's asthma drug Fasenra (be
Professors at the University of Ulsan College of Medicine, including those at Asan Medical Center (AMC) in Seoul, have agreed to submit their resignations in protest against the government's decision to suspend the licenses of resigned interns and residents.The emergency committee of the University
The government allowed "physician assistant" (PA) nurses to practice more at healthcare sites from Friday, issuing supplementary guidelines on the scope of practice for nurses amid ongoing walkouts by trainee doctors and ensuing medical disruptions.The move came as neither trainee doctors nor the go
A research team -- led by Professor Kim Beom-joon of the Neurology Department at Seoul National University Bundang Hospital (SNUBH), together with Professor Kang Dong-Wan from the Neurology Department of the Gyeonggi Provincial Medical Center Icheon Hospital -- has received the "2024 Paul Dudley Whi
In a groundbreaking effort to combat cardiovascular diseases (CVDs) in Asia-Pacific, the Asia-Pacific Cardiovascular Disease Alliance recently released the "A Call for Cohesive Action: Redefining Cardiovascular Care Report," which underscored the region's unique position and ongoing efforts to curb
In response to a mass resignation of trainee physicians that has led to significant medical disruptions, the Korean government said it would spend 200 billion won ($150.1 million) per month into the healthcare system to maintain emergency and patient care.The Ministry of Health and Welfare on Thursd
Samsung Pharm has received approval from the Ministry of Food and Drug Safety (MFDS) to change the investigative new drug (IND) application for its phase 3 clinical trial of GV1001 for Alzheimer's disease.The MFDS accepted Samsung Pharm's application to simplify GV1001's dosing regimen, approving a
Shaperon, a Korean biotech company, said Thursday that it has completed enrollment of the first patient in its U.S. phase 2 clinical trial of NuGel for treating atopic dermatitis.The trial is designed to evaluate NuGel in 210 patients of various ethnicities with mild to moderate atopic dermatitis fo
The 10th Cancer Disease Review Committee (CDRC), under the Health Insurance Review and Assessment Service (HIRA), held its first meeting with newly reconstituted members on Wednesday, during which it discussed nine new and expanded reimbursement proposals.However, most drugs did not pass the review,
In a significant milestone marking the ten-year collaboration between SK bioscience and Sanofi, a global leader in healthcare, the two companies have embarked on an ambitious expansion of the L HOUSE, SK bioscience’s vaccine manufacturing plant in Andong, North Gyeongsang Province.This expansion aim
Concerns are mounting that the government’s push to increase medical school enrollment quota could trigger “medical school craze” among office workers.Some private educational institutions, called hagwon in Korean, and online lecturing firms are “encouraging” office workers to study and apply to med
My Feb. 22 post on X, formerly Twitter, garnered 412,000 views, 723 retweets, and 709 likes as of March 1 at noon. Two days before Daeboreum, a Korean holiday commemorating the first full moon of the New Lunar Year, I shared a brief insight into its significance and attached a photo showcasing tradi